Q: Abcellera is up 16% over 5 days. Any news driving this ?
5i Research Answer:
ABCL is still down 26% for the year. There has been no recent company news, but the sector has gotten a boost from NVDA's $50M investment in RXRX. Essentially, the biotech sector is catching a bit of the AI party right now.
Authors of this answer, directors, partners and/or officers of 5i Research and/or affiliated companies have a financial or other interest in NVDA.